PT  - JOURNAL ARTICLE
AU  - Nico J. J. Arezza
AU  - Mohammad Omer
AU  - Corey A. Baron
TI  - Estimation of free water-corrected microscopic fractional anisotropy
AID  - 10.1101/2022.10.27.22281560
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.10.27.22281560
4099  - http://medrxiv.org/content/early/2022/11/01/2022.10.27.22281560.short
4100  - http://medrxiv.org/content/early/2022/11/01/2022.10.27.22281560.full
AB  - Water diffusion anisotropy MRI is sensitive to microstructural changes in the brain that are hallmarks of various neurological conditions. However, conventional metrics like fractional anisotropy are confounded by neuron fiber orientation dispersion, and the relatively low resolution of diffusion-weighted MRI gives rise to significant free water partial volume effects in many brain regions. Microscopic fractional anisotropy is a recent metric that can report water diffusion anisotropy independent of neuron fiber orientation dispersion but is still susceptible to free water contamination. In this paper, we present a free water elimination (FWE) technique to estimate microscopic fractional anisotropy and other related diffusion indices by implementing a model in which the MRI signal within a voxel is assumed to come from two distinct sources: a tissue compartment and a free water compartment. A two-part algorithm is proposed to rapidly fit a set of diffusion-weighted MRI volumes containing both linear- and spherical-tensor encoding acquisitions to the model. Simulations and in vivo acquisitions with four healthy volunteers indicated that the FWE method may be a feasible technique for measuring microscopic fractional anisotropy and other indices with greater specificity to neural tissue characteristics than conventional methods.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) under Grant Number RGPIN-2018-05448, Canada Research Chairs (950-231993), Canada First Research Excellence Fund to BrainsCAN, and the NSERC Postgraduate Doctoral Scholarship (PGS-D) program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board at Western University gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://osf.io/etkgx/ https://osf.io/etkgx/